Immune checkpoint gene signature assesses immune infiltration profiles in bladder cancer and identifies KRT23 as an immunotherapeutic target.

Autor: Chen, Dongshan1,2 (AUTHOR), Cao, Haoyuan1 (AUTHOR), Zheng, Xiang1 (AUTHOR), Wang, Haojun1 (AUTHOR), Han, Zengchi3 (AUTHOR) hzc3203@163.com, Wang, Wei1 (AUTHOR) weiwang0920@163.com
Zdroj: BMC Cancer. 8/19/2024, Vol. 24 Issue 1, p1-20. 20p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje